Suchergebnisse - "Salazar, Ramon"

PubPharm (186)

1

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS-mutant metastatic colorectal cancer

enthalten in: Molecular oncology | 2019

von Elez, E. | Chianese, C. | Sanz-García, E. | +22

2

Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma : TGFBR1 and TAK1 Inhibition in Colorectal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Guillén Díaz-Maroto, N. | Sanz-Pamplona, R. | Berdiel-Acer, M. | +10

3

Carcinoembryonic Antigen Levels and Survival in Stage III Colon Cancer : Post hoc Analysis of the MOSAIC and PETACC-8 Trials

enthalten in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | 2019

von Auclin, E. | Taieb, J. | Lepage, C. | +14

4

A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients

enthalten in: Human gene therapy | 2019

von García, M. | Moreno, R. | Gil-Martin, M. | +8

5

Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms

enthalten in: Neuroendocrinology | 2019

von Capdevila, J. | Bodei, L. | Davies, P. | +67

6

A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)

enthalten in: Journal for immunotherapy of cancer | 2019

von Machiels, J. | Salazar, R. | Rottey, S. | +11

CommentIn: J Immunother Cancer. 2019 Feb 1;7(1):26. - PMID 30709365

7

A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Machiels, J. | Salazar, R. | Rottey, S. | +11

8

A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Machiels, J. | Salazar, R. | Rottey, S. | +11

9

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors : The GETNE1003_EVERLAR Study

enthalten in: The oncologist | 2019

von Capdevila, J. | Teulé, A. | Barriuso, J. | +11

10

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer

enthalten in: Molecular Oncology | 2019

von Elez, E. | Chianese, C. | Sanz‐García, E. | +22

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]